Akut limfoid leukémia (ALL): vizsgálatok itt: Kanada
30 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
- Where
- Calgary, Edmonton
- Életkor
- 2 év to 70 év
- People
- 63
- Run by
- University of Alberta
See details and how to joinNCT03938987 - No phaseTaking peopleHIIT in Youth With Congenital Heart Disease (MedBIKE)
- Where
- Edmonton
- Életkor
- 10 év to 18 év
- People
- 44
- Run by
- University of Alberta
See details and how to joinNCT04575883 - 1. fázisTaking peopleStudy of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 242 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT04260022 - 1/2. fázisTaking peopleCLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
- Where
- Ottawa, Vancouver, Winnipeg
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT03765177 - No phaseTaking peopleBright Ideas - CIN Feasibility Study
- Where
- Toronto
- Életkor
- 4 év to 18 év
- People
- 75 worldwide
- Run by
- The Hospital for Sick Children
See details and how to joinNCT04929899